Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist

Details for Australian Patent Application No. 2010326798 (hide)

Owner Glaxo Group Limited

Inventors Baker, Darrell; Bruce, Mark; Crater, Glenn; Noga, Brian; Thomas, Marian; Wire, Patrick

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010326798

PCT Pub. Number WO2011/067212

Priority 0921075.8 01.12.09 GB

Filing date 29 November 2010

Wipo publication date 9 June 2011

International Classifications

A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 11/06 Drugs for disorders of the respiratory system

A61P 11/08 Drugs for disorders of the respiratory system

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/067212 Priority application(s): WO2011/067212

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010326801-Detection gate

2010326791-Pesticidal mixtures of triazamate with strobilurines